1. Home
  2. GHLD vs AUPH Comparison

GHLD vs AUPH Comparison

Compare GHLD & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • AUPH
  • Stock Information
  • Founded
  • GHLD 1960
  • AUPH 1993
  • Country
  • GHLD United States
  • AUPH Canada
  • Employees
  • GHLD N/A
  • AUPH N/A
  • Industry
  • GHLD Finance: Consumer Services
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • GHLD Finance
  • AUPH Health Care
  • Exchange
  • GHLD Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • GHLD 1.0B
  • AUPH 1.0B
  • IPO Year
  • GHLD 2020
  • AUPH 1999
  • Fundamental
  • Price
  • GHLD $14.63
  • AUPH $8.34
  • Analyst Decision
  • GHLD Buy
  • AUPH Strong Buy
  • Analyst Count
  • GHLD 5
  • AUPH 3
  • Target Price
  • GHLD $16.60
  • AUPH $10.33
  • AVG Volume (30 Days)
  • GHLD 13.6K
  • AUPH 934.2K
  • Earning Date
  • GHLD 11-06-2024
  • AUPH 11-07-2024
  • Dividend Yield
  • GHLD 3.50%
  • AUPH N/A
  • EPS Growth
  • GHLD N/A
  • AUPH N/A
  • EPS
  • GHLD N/A
  • AUPH N/A
  • Revenue
  • GHLD $829,864,000.00
  • AUPH $220,361,000.00
  • Revenue This Year
  • GHLD $63.54
  • AUPH $36.08
  • Revenue Next Year
  • GHLD $19.66
  • AUPH $19.41
  • P/E Ratio
  • GHLD N/A
  • AUPH N/A
  • Revenue Growth
  • GHLD 4.51
  • AUPH 38.72
  • 52 Week Low
  • GHLD $9.59
  • AUPH $4.71
  • 52 Week High
  • GHLD $18.26
  • AUPH $10.05
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 46.24
  • AUPH 74.66
  • Support Level
  • GHLD $13.97
  • AUPH $7.03
  • Resistance Level
  • GHLD $14.60
  • AUPH $7.50
  • Average True Range (ATR)
  • GHLD 0.44
  • AUPH 0.27
  • MACD
  • GHLD 0.02
  • AUPH 0.08
  • Stochastic Oscillator
  • GHLD 38.23
  • AUPH 78.84

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: